Review Registration - Organization

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 543973
Submitted by lobbyist on: March 28, 2016 11:58:13 AM
Accepted by Registrar on: April 4, 2016 11:57:38 AM

Designated Filer Information

Keon, James J  
4120 Yonge Street Suite 409  
Toronto, ON, M2P 2B8
 416-223-2333
Canada  

Organization Information

Canadian Generic Pharmaceutical Association (CGPA)  
The CGPA's mission is to promote an environment which supports and enhances the provision of affordable generic medications to Canadians and patients around the world. The Association researches and develops positions regarding a wide variety of policies, regulations and legislation that affects our member companies. We promote our sector's interests by publishing material as well as directly contacting government officials, the media and other opinion leaders and decision makers.
4120 Yonge Street Suite 409  
Toronto, ON, M2P 2B8
 416-223-2333
Canada  

Relevant Affiliates

The client has no relevant affiliates.

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

March 28, 2016  
September 24, 2016  

Organization's In-House Lobbyists

 



Name: Connell, Jeff
 
March 28, 2016  
Inactivation Date: October 13, 2016

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Introduction, modification or repeal of legislation, a bill or regulation

Alignment of British Columbia's listing and pricing policies for generic drugs with that of the pan-Canadian National Pharmaceutical Alliance. Addressing delays in listing certain generic drugs due to requirement of a Ministerial Order and discussion of alternatives. Addressing impact of expansion and modification of Reference Drug Program on generic manufacturers. Addressing potential amendments to Drug Price Regulation regarding annual listing process for generic drugs. Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Lake, Terry Minister of Health March 28, 2016
Public Agency Health March 28, 2016
Public Agency Office of the Premier March 28, 2016

International Trade

Development, establishment, amendment or termination of any program, policy or decision

Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency International Trade March 28, 2016

Name: Cox, Jody
 
March 28, 2016  
Inactivation Date: October 13, 2016

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

International Trade

Development, establishment, amendment or termination of any program, policy or decision

Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency International Trade March 28, 2016

Name: Keon, James
 
March 28, 2016  
Inactivation Date: October 13, 2016

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Introduction, modification or repeal of legislation, a bill or regulation

Alignment of British Columbia's listing and pricing policies for generic drugs with that of the pan-Canadian National Pharmaceutical Alliance. Addressing delays in listing certain generic drugs due to requirement of a Ministerial Order and discussion of alternatives. Addressing impact of expansion and modification of Reference Drug Program on generic manufacturers. Addressing potential amendments to Drug Price Regulation regarding annual listing process for generic drugs. Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Lake, Terry Minister of Health March 28, 2016
Public Agency Health March 28, 2016
Public Agency Office of the Premier March 28, 2016

International Trade

Development, establishment, amendment or termination of any program, policy or decision

Protecting the interests of Canada's generic pharmaceutical industry should the Trans-Pacific partnership be ratified and during implementation of the Comprehensive Economic and Trade Agreement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency International Trade March 28, 2016